- FDA criticizes Lundbeck for webpages on migraine treatment VyeptiThe FDA has chastised Lundbeck Seattle Biopharmaceuticals for two promotional webpages that made allegedly inflated claims regarding the efficacy of its migraine drug. In an untitled letter sent…Endpoints · 17d ago↗ source
- FDA quietly stops releasing CRLsThe FDA has paused its public release of pharma rejection letters as the agency seeks to avoid litigation around releasing the often sensitive information. The pause follows a law firm in AprilEndpoints · 17d ago↗ source
- Outbreak of diarrhea-causing parasite grows to more than 1,000 casesAn outbreak of diarrhea-causing parasite has grown to more than 1,000 cases, making it one of the nation’s largest such outbreaks in years.STAT · 17d ago